Objectives-To investigate whether interstitial collagenase (MMP-1) concentration in synovial fluid can be useful as a marker for disease activity in rheumatoid arthritis (RA), to determine the main route by which collagenase degrades the matrix of articular cartlage, and to investigate if an imbalance between metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMP) is responsible for the activity ofMMPs in RA. Methods-Collagenase concentrations were measured in synovial fluid and paired serum samples using a specific sandwich enzyme linked immunosorbent assay. Coliagenase activities were also assayed in synovial fluid samples. Synovial tissues obtained from the same patient were examined by inmunohistochemical staining and the numbers of cells expressing collagenase were counted.
examined by inmunohistochemical staining and the numbers of cells expressing collagenase were counted. Results-Collagenase concentrations in synovial fluid did not correlate with C reactive protein and collagenase levels in serum, but did correlate positively with the degree of synovial inflammation, and increased with increasing numbers of cells identified as expressing collagenase in synovial tissue. Collagenase activities did not correlate with TIMP-1 concentrations, but did correlate strongly with the ratios of collagenase concentration to TIMP-1 (r=0-73). Conclusion-The collagenase concentration in synovial fluid cannot be used as a marker for systemic disease activity, but can be used as a marker for the degree of synovial inflammation in the joint from which the sample is aspirated. In advanced RA, most of the collagenase is probably produced in synovial lining cells and released into synovial fluid, where it degrades the matrix of articular cartilage. MMP-1) is a member of the MMP gene family that cleaves the collagen triple helix to yield characteristic 1/4-3/4 products.2
Explants from human rheumatoid synovial tissue have been found to release large amounts of collagenase,3 and increased collagenase activity has been reported in rheumatoid synovial fluid. 4 Collagenase was localised by immunostaining on the extracellular matrix components at the cartilage-pannus junction in RA,5 and immunohistochemical staining has subsequently shown it to be localised intracellularly in hyperplastic synovial lining cells of the rheumatoid synovium.6 However, it has also been reported that chondrocytes produce proteinases capable of degrading osteoarthritic and normal human cartilage,7 8 Figure 1 illustrates the relationship between the concentration of collagenase in synovial fluid and the inflammation score classes. Six patients were in class 3+, 11 were in class 2+, 12 were in class 1 +, and six were in class 0. The concentrations of collagenase in synovial fluid from patients with class 3+ inflammation ranged from 1991 to 11712 ng/ml (mean (SD) 4954 (3723) ng/ml (n = 6)); the values for class 2+ patients ranged from 478 to 11158 ng/ml (3790 (3163) ng/ml (n = 11)); those of class 1+ patients were from 320 to 6398 ng/ml (2400 (2182) ng/ml (n = 12)); and those of class 0 patients ranged from 97 to 1820 ng/ml (953 (707) ng/ml (n = 6)). A positive correlation was observed between the degree of synovial inflammation and the collagenase concentration in synovial fluid.
RELATIONSHIP BETWEEN GRADE FOR POSITIVE CELL COUNT AND COLLAGENASE CONCENTRATIONS IN SYNOVIAL FLUID
Collagenase was immunolocalised in hyperplastic synovial lining cells in rheumatoid synovium. Figure 2 shows a haematoxylin and eosin stained section of synovial tissue and a serial section from the same synovium analysed for expression of collagenase by immunohistochemical staining. Very little staining was found in chondrocytes and fibroblasts at the cartilage-pannus junction.
With our system of grading by the number of cells immunohistochemically positive for collagenase expression, nine patients were grade 3+, nine were grade 2+, five were grade 1 +, and 11 were grade 0. Figure 3 shows the collagenase concentrations in synovial fluid taken from patients belonging to each grade; concentrations in patients from grade 3+ ranged from 1189 to 11712 ng/ml (mean (SD) 4430 (3197) ng/ml (n = 9)); in grade 2+ patients they were from 924 to 11158 ng/ml (4954 (3157) ng/ml (n = 9)); those in grade 1+ patients ranged from 1609 to 3451 ng/ml (2346 (754) ng/ml (n = 5)); and concentrations in grade 0 patients ranged from 96 to 2040 ng/ml (842 (712) ng/ml (n= 11)). Collagenase levels in synovial fluid tended to increase with increasing numbers of positive cells, and a positive correlation existed between the degree of collagenase expression in synovial tissue and the collagenase concentrations in synovial fluid. Collagenase activity (U/ml) Figure 5 Relationship between collagenase activities and the ratios of the concentration ofcollagenase to that of TIMP-1 in synovialfluid.
We also compared synovial fluid concentrations with the degree of synovial inflammation. Using in situ hybridisation, Firestein et al reported a positive correlation between the degree of synovial inflammation and expression of collagenase mRNA in synovial tissue.29 In our study, concentrations of collagenase in synovial fluid correlated with the degree of synovial inflammation. These data complement previous reports that cytokines derived from inflammatory cells, such as interleukin-1 and tumour necrosis factor, can modulate the amount of collagenase synthesised.3"34 While synovial fluid concentration of collagenase cannot be used as a marker for systemic disease activity, it can be used as a marker for the degree of synovial inflammation in the joint from which the sample is aspirated.
Collagenase has been immunolocalised in hyperplastic lining cells in rheumatoid synovium using an immunohistochemical method,6 and in situ hybridisation studies have also demonstrated production of collagenase mRNA in rheumatoid synovial lining cells.29 35 36 We applied monospecific antibodies against collagenase to synovium, cartilage, and the cartilage-pannus junction in the RA joint and were able to immunolocalise collagenase in synovial lining cells; very little staining was found in chondrocytes and fibroblasts at the cartilage-pannus junction. Woolley et al reported immunolocalisation of collagenase in the extracellular matrix at the cartilage-pannus junction, but the cells producing collagenase could not be identified. 5 37 In the present study, collagenase was immunolocalised in synovial lining cells, but very little staining was found in the chondrocytes of articular cartilage and in the fibroblasts at the cartilage-pannus junction. A relationship was demonstrated between the degree of expression of collagenase in synovial tissue and the concentration of collagenase in synovial fluid. These data suggest that, as far as collagenase is concerned, synovial cells are more important in the breakdown of the cartilage matrix than are chondrocytes. It has also been suggested that collagenase participates in the destruction of the entire cartilage surface, not just that of a localised area such as the cartilage-pannus junction. Hasty et al studied rats with collagen induced arthritis and proposed that chondrocytes may play a direct part in the earliest stages of degradation of their own matrix. 38 In the present study, we obtained all samples at the time of total knee joint replacement surgery and thus cannot comment on the importance of chondrocytes in the initial stage of RA. Our findings do suggest that, in advanced RA, most of the collagenase is produced in synovial lining cells and released into synovial fluid, where it degrades the articular cartilage matrix.
Both active and latent collagenase have been shown to be present in rheumatoid synovial fluid,39 40 and an inhibitor of collagenase demonstrated in newborn rabbit bone, TIMP, has been shown to bind to activated collagenase. 18 19 It has been proposed that an imbalance between MMPs such as collagenase and TIMP contributes to the pathogenesis of OA. 20 We measured collagenase activities and TIMP-1 concentrations in synovial fluid, using an assay that included activation with trypsin. It is known that collagenase inhibitors such as TIMP-1, TIMP-2, and O2-macroglobulin may be inactivated by trypsin treatment, and thus the results of our assay may be overestimates. However, little active collagenase has been detected in synovial fluid,4" and the assay is not capable of measuring collagenase activity without the addition of an activating agent such as trypsin. We found no positive correlation between collagenase and TIMP-1 concentrations. This result is consistent with that reported by Clark et al.42 It has been reported that procollagenase is secreted as both a minor glycosylated form and a major polypeptide.43 Both the 57 kDa and the 52 kDa procollagenase could be activated by trypsin, generating their respective 47 kDa and 42 kDa active enzyme forms. 43 In the present study, the extent to which procollagenase contributes to the total (latent + active) concentration of collagenase in synovial fluid could not be determined; even when the concentration of total collagenase was assayed, an accurate molarity could not be calculated. It has previously been reported that no appreciable amount of apparently active collagenase was present in synovial fluid, the majority of the collagenase being in the latent form.4' If this is so, the ratio of concentrations of collagenase and TIMP will correspond approximately with the ratio of the molarity between them. We found a strong positive correlation between collagenase activity and the collagenase:TIMP ratio (r= 073, p = 00001). These data support the concept that an imbalance between MMP and TIMP is responsible for the degradation of extracellular matrix which occurs in RA.
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